BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32474013)

  • 21. In vivo Mn-enhanced MRI for early tumor detection and growth rate analysis in a mouse medulloblastoma model.
    Suero-Abreu GA; Praveen Raju G; Aristizábal O; Volkova E; Wojcinski A; Houston EJ; Pham D; Szulc KU; Colon D; Joyner AL; Turnbull DH
    Neoplasia; 2014 Dec; 16(12):993-1006. PubMed ID: 25499213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation Between Ependymoma and Medulloblastoma in Children with Radiomics Approach.
    Dong J; Li L; Liang S; Zhao S; Zhang B; Meng Y; Zhang Y; Li S
    Acad Radiol; 2021 Mar; 28(3):318-327. PubMed ID: 32222329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.
    Blüml S; Margol AS; Sposto R; Kennedy RJ; Robison NJ; Vali M; Hung LT; Muthugounder S; Finlay JL; Erdreich-Epstein A; Gilles FH; Judkins AR; Krieger MD; Dhall G; Nelson MD; Asgharzadeh S
    Neuro Oncol; 2016 Jan; 18(1):126-31. PubMed ID: 26254476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mining the human urine proteome for monitoring renal transplant injury.
    Sigdel TK; Gao Y; He J; Wang A; Nicora CD; Fillmore TL; Shi T; Webb-Robertson BJ; Smith RD; Qian WJ; Salvatierra O; Camp DG; Sarwal MM
    Kidney Int; 2016 Jun; 89(6):1244-52. PubMed ID: 27165815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.
    Siwy J; Zürbig P; Argiles A; Beige J; Haubitz M; Jankowski J; Julian BA; Linde PG; Marx D; Mischak H; Mullen W; Novak J; Ortiz A; Persson F; Pontillo C; Rossing P; Rupprecht H; Schanstra JP; Vlahou A; Vanholder R
    Nephrol Dial Transplant; 2017 Dec; 32(12):2079-2089. PubMed ID: 27984204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of Potential Serum Protein Biomarkers in Ankylosing Spondylitis Using Tandem Mass Tag-Based Quantitative Proteomics.
    Liu S; Ji W; Lu J; Tang X; Guo Y; Ji M; Xu T; Gu W; Kong D; Shen Q; Wang D; Lv X; Wang J; Zhu T; Zhu Y; Liu P; Su J; Wang L; Li Y; Gao P; Liu W; Sun L; Yin X; Zhou W
    J Proteome Res; 2020 Feb; 19(2):864-872. PubMed ID: 31917576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach.
    Le Large TYS; Meijer LL; Paleckyte R; Boyd LNC; Kok B; Wurdinger T; Schelfhorst T; Piersma SR; Pham TV; van Grieken NCT; Zonderhuis BM; Daams F; van Laarhoven HWM; Bijlsma MF; Jimenez CR; Giovannetti E; Kazemier G
    Oncologist; 2020 Apr; 25(4):e634-e643. PubMed ID: 31943574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medulloblastoma in children: CT and MRI findings.
    Tortori-Donati P; Fondelli MP; Rossi A; Cama A; Caputo L; Andreussi L; Garré ML
    Neuroradiology; 1996 May; 38(4):352-9. PubMed ID: 8738095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beijing Children's Hospital guidelines on the design and conduction of the first standardized database for medulloblastoma.
    Yang W; Ma W; Huang J; Cai Y; Peng X; Zhao F; Zhang D; Zou Z; Sun H; Qi X; Ge M
    Metab Brain Dis; 2023 Oct; 38(7):2393-2400. PubMed ID: 37261631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.
    Yoneyama T; Ohtsuki S; Honda K; Kobayashi M; Iwasaki M; Uchida Y; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Huang W; Yamada T; Tachikawa M; Terasaki T
    PLoS One; 2016; 11(8):e0161009. PubMed ID: 27579675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary proteome profiling for children with autism using data-independent acquisition proteomics.
    Meng W; Huan Y; Gao Y
    Transl Pediatr; 2021 Jul; 10(7):1765-1778. PubMed ID: 34430425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic profiling of high risk medulloblastoma reveals functional biology.
    Staal JA; Lau LS; Zhang H; Ingram WJ; Hallahan AR; Northcott PA; Pfister SM; Wechsler-Reya RJ; Rusert JM; Taylor MD; Cho YJ; Packer RJ; Brown KJ; Rood BR
    Oncotarget; 2015 Jun; 6(16):14584-95. PubMed ID: 25970789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA profiling of pediatric Medulloblastoma.
    Kesherwani V; Shukla M; Coulter DW; Sharp JG; Joshi SS; Chaturvedi NK
    BMC Med Genomics; 2020 Jun; 13(1):87. PubMed ID: 32591022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated urine histone 4 levels in women with ovarian endometriosis revealed by discovery and parallel reaction monitoring proteomics.
    Chen X; Liu H; Sun W; Guo Z; Lang J
    J Proteomics; 2019 Jul; 204():103398. PubMed ID: 31146047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic urinary proteomic analysis in a Walker 256 intracerebral tumor model.
    Zhang L; Li Y; Meng W; Ni Y; Gao Y
    Cancer Med; 2019 Jul; 8(7):3553-3565. PubMed ID: 31090175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation - a pilot study.
    Kanzelmeyer NK; Zürbig P; Mischak H; Metzger J; Fichtner A; Ruszai KH; Seemann T; Hansen M; Wygoda S; Krupka K; Tönshoff B; Melk A; Pape L
    Transpl Int; 2019 Jan; 32(1):28-37. PubMed ID: 30357927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis.
    Heidari SS; Nafar M; Kalantari S; Tavilani H; Karimi J; Foster L; Moon KM; Khodadadi I
    J Proteomics; 2021 May; 240():104208. PubMed ID: 33785428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.
    Han C; Bellone S; Siegel ER; Altwerger G; Menderes G; Bonazzoli E; Egawa-Takata T; Pettinella F; Bianchi A; Riccio F; Zammataro L; Yadav G; Marto JA; Penet MF; Levine DA; Drapkin R; Patel A; Litkouhi B; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Santin AD
    Gynecol Oncol; 2018 Jun; 149(3):585-591. PubMed ID: 29572027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 111In-pentetreotide scintigraphy in medulloblastoma: a comparison with magnetic resonance imaging.
    Yüksel M; Lutterbey G; Biersack HJ; Elke U; Hasan C; Gao Z; Bode U; Ezziddin S
    Acta Oncol; 2007; 46(1):111-7. PubMed ID: 17438713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis and Phenotyping of Carotid Artery Stenosis.
    Wang W; Wu J; Liu P; Tang X; Pang H; Xie T; Xu F; Shao J; Chen Y; Liu B; Zheng Y
    Front Mol Biosci; 2021; 8():714706. PubMed ID: 34447787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.